Skip to content
DNA·NYSE·US

Ginkgo Bioworks

Ginkgo Bioworks is a synthetic biology company that sells cell engineering, biological design, and biosecurity services to customers across biopharma, industrial, agricultural, and government markets. It generates revenue primarily through service and license agreements tied to its platform and downstream partner programs.

Thematic Position

Relationship Groups

Suppliers3
Partners5
Competitors3

Relationship details are part of the Pro plan.

Ended Relationships

14 ended relationships · Ended relationships are part of the Pro plan.

Management Perspective on Regulatory & Geopolitical Developments

export controlgovernment rightslicensing restriction
U.S. Bayh-Dole Act grants government rights over federally funded Ginkgo inventions
SEC 10-KFeb 26, 2026

The full regulatory passage is part of the Pro plan.

19 more · Regulatory and geopolitical insights are part of the Pro plan.